CASI Pharmaceuticals, Inc. (CASIF)

CASI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.63	13.47	17.08	47.11	38.7
Short-Term Investments	-	2.62	13.69	4.23	9.87
Cash & Short-Term Investments	5.63	16.09	30.77	51.34	48.57
Cash Growth	-65.00%	-47.70%	-40.06%	5.69%	-26.82%
Accounts Receivable	4.09	15.35	9.55	12.97	9.8
Other Receivables	-	-	0.59	-	-
Total Trade Receivables	4.09	15.35	10.14	12.97	9.8
Inventory	1.6	5.25	15.88	6.14	1.91
Other Current Assets	2.14	2.89	2.56	2.98	1.69
Total Current Assets	13.46	39.58	59.34	73.42	61.97
Net Property, Plant & Equipment	9.52	11.36	11.63	13.23	21.82
Other Intangible Assets	0.22	0.24	1.84	1.06	12.2
Long-Term Investments	1.72	1.91	1.69	4.4	40.13
Other Long-Term Assets	0.74	0.59	0.77	4.12	2.18
Total Assets	25.65	53.67	75.27	96.23	138.3

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.07	2.72	4.44	3.29	4.79
Accrued Expenses	24.17	15.34	12.29	11.82	8.4
Short-Term Debt	5.24	-	-	-	-
Current Portion of Long-Term Debt	19.19	18.39	-	-	-
Other Current Liabilities	-	-	-	1.9	-
Total Current Liabilities	49.67	36.45	16.73	17.01	13.19
Long-Term Debt	-	-	18.9	-	-
Other Long-Term Liabilities	13.26	15.37	15.48	12.3	17.15
Total Long-Term Liabilities	13.26	15.37	34.38	12.3	17.15
Total Liabilities	62.93	51.82	51.1	29.3	30.34

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	1.4
Treasury Stock	-9.6	-9.6	-9.6	-9.33	-8.03
Additional Paid-in Capital	722.24	713.3	695.79	691.77	694.83
Accumulated Other Comprehensive Income	-1.79	-1.77	-1.2	-0.7	1.95
Retained Earnings	-748.13	-700.08	-660.82	-637.16	-605.64
Total Common Shareholders' Equity	-37.28	1.85	24.17	44.57	84.5
Minority Interest	-	-	-	22.36	23.46
Shareholders' Equity	-37.28	1.85	24.17	66.93	107.96
Total Liabilities & Equity	25.65	53.67	75.27	96.23	138.3

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	24.43	18.39	18.9	0	0
Net Cash (Debt)	-18.8	-2.29	11.87	51.34	48.57
Net Cash Growth	-	-	-76.87%	5.69%	-25.37%
Net Cash Per Share	-1.01	-0.15	0.89	3.76	3.57
Book Value	-37.28	1.85	24.17	44.57	84.5
Book Value Per Share	-2.01	0.12	1.81	3.27	6.21
Tangible Book Value	-37.5	1.61	22.33	43.51	72.3
Tangible Book Value Per Share	-2.02	0.11	1.67	3.19	5.31

Data Source: Fiscal.ai Last updated: May 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error